|
| |
argos therapeutics North Carolina Pages on BioPortfolio:
BioPortfolio - Argos Therapeutics - Profile
Research and Development Department, Argos Therapeutics Inc, Durham, NC,- BMC Mol ... Argos Therapeutics, 4233 Technology Drive, Durham, NC, United States.
...
http://www.bioportfolio.com/biocorporate/18700-Argos%2BThera...
|
Biotechnology News Cell Therapeutics Search
DURHAM, N.C.--(BUSINESS WIRE)--Argos Therapeutics today announced the closing of the second and final tranche of a $35.2 million Series C financing from a ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...
|
BioPortfolio - Argos Therapeutics
Research Department, Argos Therapeutics, Inc, Durham, NC 27704, USA. J Immunol. 2008 Oct 15;181(8):5296-305. Cytokine maturation followed by CD40L mRNA ...
http://www.bioportfolio.com/biocorporate/18700-Argos_Therape...
|
BioPortfolio - Biocorporate Search North Carolina
Biocorporate Search North Carolina - Entry on Bioportfolio's Biocorporate Database. ... Argos Therapeutics, incorporated in 1997 and operated under the
name ...
http://www.bioportfolio.com/biocorporate/search/region/North...
|
BioPortfolio - Carcinoma Renal Cell - InDepth
Argos Therapeutics Completes $35.2 Million Series C Financing ... New nephrectomy data have been reported by scientists at University of North
Carolina ...
http://www.bioportfolio.com/indepth/Carcinoma_Renal_Cell.pdf...
|
BioPortfolio - RNA Caps
19th November, 2008, Research and Development Department, Argos Therapeutics Inc , Durham, NC,, BMC Mol Biol. 2008 Oct 17;9:90. DOI Direct Link ...
http://www.bioportfolio.com/indepth/RNA_Caps.html...
|
BioPortfolio - IL2 - interleukin 2
Research Department, Argos Therapeutics, Inc, Durham, NC 27704, USA. J Immunol. 2008 Oct 15;181(8):5296-305. →View more research publications. ...
http://www.bioportfolio.com/gene/3558-IL2.html...
|
BioPortfolio - Immunologic Memory - InDepth
Research Department, Argos Therapeutics, Inc, Durham, NC 27704, USA. ... 7235392 - Apoptotic EBV-transformed lymphocytes, a therapeutic agent for post- ...
http://www.bioportfolio.com/indepth/Immunologic_Memory.pdf...
|
BioPortfolio - Biocorporate Search Durham
Blue Cross and Blue Shield of North Carolina (BCBSNC) is a leader in ... Argos Therapeutics, incorporated in 1997 and operated under the name Merix ...
http://www.bioportfolio.com/biocorporate/search/city/Durham....
|
BioPortfolio - APEX Biosciences Inc
Apex Bioscience, Inc. NC, Durham. Argos Technologies, Inc. FKA: Integra Biosciences, Inc. IL, East Dundee. Argos Therapeutics, Inc. FKA: Merix
Bioscience . ...
http://www.bioportfolio.com/search/APEX_Biosciences_Inc.html...
|
Results from other life science and pharmaceutical sites:
BioSpace - Argos Therapeutics, Inc. News, Search Jobs, Events
Argos Therapeutics, Inc. (Formerly Merix Bioscience) 4233 Technology Drive Durham North Carolina 27704 U.S.A.. Phone: 919-287-6300 Fax: 919-287-6301 ...
http://www.biospace.com/company_profile.aspx?CompanyId=13580...
|
BioPortfolio - Argos Therapeutics - Profile
Research and Development Department, Argos Therapeutics Inc, Durham, NC,- BMC Mol ... Argos Therapeutics, 4233 Technology Drive, Durham, NC, United States.
...
http://www.bioportfolio.com/biocorporate/18700-Argos%2BThera...
|
Argos Therapeutics, Inc. Completes $35.2 Million Series C ...
DURHAM, N.C.--(BUSINESS WIRE)--Argos Therapeutics today announced the closing of the second and final tranche of a $35.2 million Series C financing from a ...
http://www.biospace.com/news_story.aspx?NewsEntityId=118462...
|
Argos Therapeutics to Discuss Personalized Dendritic Cell ...
DURHAM, NC--(BUSINESS WIRE)--Argos Therapeutics today announced the presentation of details on the Company’s dendritic cell-based immunotherapy process, ...
http://biz.yahoo.com/bw/081031/20081031005102.html?.v=1...
|
Argos Therapeutics, Inc. And Beckman Coulter, Inc. Sign License ...
DURHAM, N.C.--(BUSINESS WIRE)--April 26, 2006--Argos Therapeutics, a company pioneering new approaches in immunotherapy, announced today that it has entered
...
http://www.biospace.com/news_story.aspx?NewsEntityId=16480...
|
IRB Details
10 Oct 2008 ... FWA00010561, Argos Therapeutics, Inc. Durham, NORTH CAROLINA, Detail. FWA00011413, Tenet HealthSystem Hahnemann, LLC, Philadelphia ...
http://ohrp.cit.nih.gov/search/irbdtl.asp?IRBID=658...
|
Argos Therapeutics, Inc. to Discuss Automated Manufacturing ...
DURHAM, N.C.--(BUSINESS WIRE)--Argos Therapeutics today announced that Tamara Monesmith, Director of Manufacturing and Process Development, will present ...
http://www.biospace.com/news_story.aspx?NewsEntityId=103149...
|
Evotec / About us / Supervisory Board / Dr Hubert Birner
He currently serves as Chairman of the Board of Argos Therapeutics Inc. (Durham, North Carolina) and is a Member of the Board of Directors of BioXell SA ...
http://www.evotec.com/en/about/hubert_birner.aspx...
|
Assurance Detail
ASSURANCE: FWA00010561 - Argos Therapeutics, Inc. Located at: Durham, NORTH CAROLINA Expires: August 28, 2009. No Assurance Components Identified ...
http://ohrp.cit.nih.gov/search/asurdtl.asp?ASURID=13111&ASUR...
|
Multiplex RT-PCR Amplification of HIV Genes to Create a Completely ...
13 Dec 2007 ... Research and Development Department, Argos Therapeutics, Inc., Durham, North Carolina, United States of America ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=22...
|
|
